Real life prospective evaluation of new drug-eluting platform for chemoembolization of patients with hepatocellular carcinoma: paris registry

HIGHLIGHTS

• who: Thierry de Baere and colleagues from the Department of Interventional Radiology, Gustave Roussy Cancer Center, rue Edouard Vaillant, UFR Médecine Le Kremlin-Bicêtre, Université Paris-Saclay, Le Kremlin-Bicêtre, France have published the research: Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry, in the Journal: (JOURNAL)
• what: The aim of this study was to assess tolerance and toxicity (hepatobiliary and systemic), safety and tumor response after DEM-TACE with LifePearl™ microspheres loaded with anthracyclines in a real-life setting. Spasm in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.